[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Global Pyelonephritis Drug Market Status and Outlook 2018-2025

July 2018 | 135 pages | ID: GA2BAC70AA0EN
99Strategy

US$ 4,000.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
REPORT SNAPSHOT

Key Content of Chapters (Including and can be customized, report is a semifinished version, and it takes 48-72 hours to upgrade)

Part 1:
Terminology Definition, Industry Chain,Industry Dynamics & Regulations and Global Market Overview
Part 2:
Upstream (Raw Materials/Components) & Manufacturing (Procurement Methods & Channels and Cost), Major Regional Production Overview and Trade Flow
Part 3:
Product Segment Overview and Market Status
Part 4:
Application/End-User Segment Overview and Market Status
Part 5:
Region Segment Overview and Market Status
Part 6:
Product & Application Segment Production & Demand by Region
Part 7:
Market Forecast by Product, Application & Region
Part 8:
Company information, Products & Services and Business Operation (Sales, Cost, Margin etc.)
Part 9:
Market Competition and Environment for New Entrants
Part 10:
Conclusion

Market Segment as follows:

Key Companies
  • Achaogen Inc
  • AstraZeneca Plc
  • Meiji Seika Pharma Co Ltd
  • Merck & Co Inc
  • MerLion Pharmaceuticals Pte Ltd
  • The Medicines Company
  • Zavante Therapeutics Inc
Market by Type
  • Finafloxacin
  • Fosfomycin Tromethamine
  • Nacubactam
  • Plazomicin Sulfate
  • Others
Market by Application
  • Hospital
  • Clinic
  • Others
PART 1 INDUSTRY OVERVIEW (200 USD)

1.1 Pyelonephritis Drug Industry
  1.1.1 Market Development
  1.1.2 Terminology Definition in the Report
    1.1.2.1 Production
    1.1.2.2 Demand
    1.1.2.3 Sales Revenue
    1.1.2.4 Ex-factory Price & Sales Price
    1.1.2.5 Cost
    1.1.2.6 Gross Margin
1.2 Products & Services Scope
1.3 Industry Chain
1.4 Industry Dynamics & Regulations
1.5 Global Market Overview

PART 2 UPSTREAM & PRODUCTION (200 USD)

2.1 Raw Materials / Components
2.2 Procurement Methods & Channels
2.3 Cost Structure & Manufacturing
2.4 Industry Capacity
2.5 Production Distribution by Geography
  2.5.1 Production in Major Regions / Countries
  2.5.2 Trade Flow Overview

PART 3 PRODUCT SEGMENT (400 USD)

3.1 Introduction by Type
  3.1.1 Finafloxacin
  3.1.2 Fosfomycin Tromethamine
  3.1.3 Nacubactam
  3.1.4 Plazomicin Sulfate
  3.1.5 Others
3.2 Market Status

PART 4 APPLICATION / END-USER SEGMENT (400 USD)

4.1 Introduction by Application
  4.1.1 Hospital
  4.1.2 Clinic
  4.1.3 Others
4.2 Market Status

PART 5 REGIONAL MARKET (600 USD)

5.1 Market Overview
5.2 by Region
  5.2.1 North America
    5.2.1.1 United States Market Size and Growth (2015-2018E)
    5.2.1.2 Canada Market Size and Growth (2015-2018E)
    5.2.1.3 Mexico Market Size and Growth (2015-2018E)
  5.2.2 Europe
    5.2.2.1 Germany Market Size and Growth (2015-2018E)
    5.2.2.2 UK Market Size and Growth (2015-2018E)
    5.2.2.3 France Market Size and Growth (2015-2018E)
    5.2.2.4 Italy Market Size and Growth (2015-2018E)
    5.2.2.5 Spain Market Size and Growth (2015-2018E)
    5.2.2.6 Netherlands Market Size and Growth (2015-2018E)
    5.2.2.7 Poland Market Size and Growth (2015-2018E)
    5.2.2.8 Belgium Market Size and Growth (2015-2018E)
    5.2.2.9 Sweden Market Size and Growth (2015-2018E)
    5.2.2.10 Austria Market Size and Growth (2015-2018E)
    5.2.2.11 Denmark Market Size and Growth (2015-2018E)
    5.2.2.12 Switzerland Market Size and Growth (2015-2018E)
    5.2.2.13 Russia Market Size and Growth (2015-2018E)
  5.2.3 Asia-Pacific
    5.2.3.1 China Market Size and Growth (2015-2018E)
    5.2.3.2 India Market Size and Growth (2015-2018E)
    5.2.3.3 Japan Market Size and Growth (2015-2018E)
    5.2.3.4 Korea Market Size and Growth (2015-2018E)
    5.2.3.5 Australia Market Size and Growth (2015-2018E)
    5.2.3.6 Indonesia Market Size and Growth (2015-2018E)
    5.2.3.7 Thailand Market Size and Growth (2015-2018E)
    5.2.3.8 Malaysia Market Size and Growth (2015-2018E)
    5.2.3.9 Singapore Market Size and Growth (2015-2018E)
    5.2.3.10 Philippines Market Size and Growth (2015-2018E)
  5.2.4 South America
    5.2.4.1 Brazil Market Size and Growth (2015-2018E)
    5.2.4.2 Argentina Market Size and Growth (2015-2018E)
    5.2.4.3 Columbia Market Size and Growth (2015-2018E)
    5.2.4.4 Chile Market Size and Growth (2015-2018E)
    5.2.4.5 Peru Market Size and Growth (2015-2018E)
    5.2.4.6 Puerto Rico Market Size and Growth (2015-2018E)
    5.2.4.7 Ecuador Market Size and Growth (2015-2018E)
  5.2.5 Middle East
    5.2.5.1 Saudi Arabia Market Size and Growth (2015-2018E)
    5.2.5.2 Iran Market Size and Growth (2015-2018E)
    5.2.5.3 UAE Market Size and Growth (2015-2018E)
    5.2.5.4 Oman Market Size and Growth (2015-2018E)
    5.2.5.5 Kuwait Market Size and Growth (2015-2018E)
    5.2.5.6 Iraq Market Size and Growth (2015-2018E)
    5.2.5.7 Turkey Market Size and Growth (2015-2018E)
  5.2.6 Africa
    5.2.6.1 South Africa Market Size and Growth (2015-2018E)
    5.2.6.2 Egypt Market Size and Growth (2015-2018E)
    5.2.6.3 Nigeria Market Size and Growth (2015-2018E)
    5.2.6.4 Algeria Market Size and Growth (2015-2018E)
    5.2.6.5 Angola Market Size and Growth (2015-2018E)
    5.2.6.6 Morocco Market Size and Growth (2015-2018E)
    5.2.6.7 Sudan Market Size and Growth (2015-2018E)

PART 6 MARKET SUBDIVISION (800 USD)

6.1 Regional Production
  6.1.1 Production by Type
    6.1.1.1 Finafloxacin Production by Region
    6.1.1.2 Fosfomycin Tromethamine Production by Region
    6.1.1.3 Nacubactam Production by Region
    6.1.1.4 Plazomicin Sulfate Production by Region
    6.1.1.5 Others Production by Region
  6.1.2 Production by Application
    6.1.2.1 Hospital Production by Region
    6.1.2.2 Clinic Production by Region
    6.1.2.3 Others Production by Region
6.2 Regional Demand
  6.2.1 Demand by Type
    6.2.1.1 Finafloxacin Demand by Region
    6.2.1.2 Fosfomycin Tromethamine Demand by Region
    6.2.1.3 Nacubactam Demand by Region
    6.2.1.4 Plazomicin Sulfate Demand by Region
    6.2.1.5 Others Demand by Region
  6.2.2 Demand by Application
    6.2.2.1 Hospital Demand by Region
    6.2.2.2 Clinic Demand by Region
    6.2.2.3 Others Demand by Region

PART 7 MARKET FORECAST (200 USD)

7.1 Global Forecast
7.2 Forecast by Type
7.3 Forecast by Application
7.4 Forecast by Region

PART 8 KEY COMPANIES LIST (600 USD)

8.1 Achaogen Inc
  8.1.2 Company Information
  8.1.2 Products & Services
  8.1.3 Business Operation
8.2 AstraZeneca Plc
  8.2.1 Company Information
  8.2.2 Products & Services
  8.2.3 Business Operation
8.3 Meiji Seika Pharma Co Ltd
  8.3.1 Company Information
  8.3.2 Products & Services
  8.3.3 Business Operation
8.4 Merck & Co Inc
  8.4.1 Company Information
  8.4.2 Products & Services
  8.4.3 Business Operation
8.5 MerLion Pharmaceuticals Pte Ltd
  8.5.1 Company Information
  8.5.2 Products & Services
  8.5.3 Business Operation
8.6 The Medicines Company
  8.6.1 Company Information
  8.6.2 Products & Services
  8.6.3 Business Operation
8.7 Zavante Therapeutics Inc
  8.7.1 Company Information
  8.7.2 Products & Services
  8.7.3 Business Operation

PART 9 COMPANY COMPETITION (500 USD)

9.1 Market by Company
9.2 Price & Gross Margin
9.3 Competitive Environment for New Entrants
  9.3.1 Michael Porter's Five Forces Model
  9.3.2 SWOT

PART 10 RESEARCH CONCLUSION (100 USD)

LIST OF TABLES

Table Pyelonephritis Drug Industry Dynamics & Regulations List
Table Global Pyelonephritis Drug Sales Revenue, Cost and Margin, 2015-2018E
Table Global Pyelonephritis Drug Market Status by Type 2015-2018E, in USD Million
Table Global Pyelonephritis Drug Market Status by Application 2015-2018E, in USD Million
Table Global Pyelonephritis Drug Market Status by Application 2015-2018E, in Volume
Table Global Pyelonephritis Drug Market by Region 2015-2018E, in USD Million
Table Global Pyelonephritis Drug Market Share by Region in 2018, in USD Million
Table Global Pyelonephritis Drug Market by Region 2015-2018E, in Volume
Table Global Pyelonephritis Drug Market Share by Region in 2018, in Volume
Table Finafloxacin Production Value by Region 2015-2018E, in USD Million
Table Finafloxacin Production Volume by Region 2015-2018E, in Volume
Table Fosfomycin Tromethamine Production Value by Region 2015-2018E, in USD Million
Table Fosfomycin Tromethamine Production Volume by Region 2015-2018E, in Volume
Table Nacubactam Production Value by Region 2015-2018E, in USD Million
Table Nacubactam Production Volume by Region 2015-2018E, in Volume
Table Plazomicin Sulfate Production Value by Region 2015-2018E, in USD Million
Table Plazomicin Sulfate Production Volume by Region 2015-2018E, in Volume
Table Others Production Value by Region 2015-2018E, in USD Million
Table Others Production Volume by Region 2015-2018E, in Volume
Table Hospital Production Value by Region 2015-2018E, in USD Million
Table Hospital Production Volume by Region 2015-2018E, in Volume
Table Clinic Production Value by Region 2015-2018E, in USD Million
Table Clinic Production Volume by Region 2015-2018E, in Volume
Table Others Production Value by Region 2015-2018E, in USD Million
Table Others Production Volume by Region 2015-2018E, in Volume
Table Finafloxacin Market Size by Region 2015-2018E, in USD Million
Table Finafloxacin Market Size by Region 2015-2018E, in Volume
Table Fosfomycin Tromethamine Market Size by Region 2015-2018E, in USD Million
Table Fosfomycin Tromethamine Market Size by Region 2015-2018E, in Volume
Table Nacubactam Market Size by Region 2015-2018E, in USD Million
Table Nacubactam Market Size by Region 2015-2018E, in Volume
Table Plazomicin Sulfate Market Size by Region 2015-2018E, in USD Million
Table Plazomicin Sulfate Market Size by Region 2015-2018E, in Volume
Table Others Market Size by Region 2015-2018E, in USD Million
Table Others Market Size by Region 2015-2018E, in Volume
Table Hospital Market Size by Region 2015-2018E, in USD Million
Table Hospital Market Size by Region 2015-2018E, in Volume
Table Clinic Market Size by Region 2015-2018E, in USD Million
Table Clinic Market Size by Region 2015-2018E, in Volume
Table Others Market Size by Region 2015-2018E, in USD Million
Table Others Market Size by Region 2015-2018E, in Volume
Table GlobalPyelonephritis Drug Forecast by Type 2019F-2025F, in USD Million
Table Pyelonephritis Drug Forecast by Type 2019F-2025F, in Volume
Table Pyelonephritis Drug Market Forecast by Application / End-User 2019F-2025F, in USD Million
Table Pyelonephritis Drug Market Forecast by Application / End-User 2019F-2025F, in Volume
Table Pyelonephritis Drug Market Forecast by Region 2019F-2025F, in USD Million
Table Pyelonephritis Drug Market Forecast by Region 2019F-2025F, in Volume
Table Achaogen Inc Information
Table Pyelonephritis Drug Sales, Cost, Margin of Achaogen Inc
Table AstraZeneca Plc Information
Table Pyelonephritis Drug Sales, Cost, Margin of AstraZeneca Plc
Table Meiji Seika Pharma Co Ltd Information
Table Pyelonephritis Drug Sales, Cost, Margin of Meiji Seika Pharma Co Ltd
Table Merck & Co Inc Information
Table Pyelonephritis Drug Sales, Cost, Margin of Merck & Co Inc
Table MerLion Pharmaceuticals Pte Ltd Information
Table Pyelonephritis Drug Sales, Cost, Margin of MerLion Pharmaceuticals Pte Ltd
Table The Medicines Company Information
Table Pyelonephritis Drug Sales, Cost, Margin of The Medicines Company
Table Zavante Therapeutics Inc Information
Table Pyelonephritis Drug Sales, Cost, Margin of Zavante Therapeutics Inc
Table Global Pyelonephritis Drug Sales Revenue by Company 2015-2017, in USD Million
Table Global Pyelonephritis Drug Sales Volume by Company 2015-2017, in Volume
Table Global Pyelonephritis Drug Sales Volume by Company in 2018, in Volume

LIST OF FIGURES

Figure Pyelonephritis Drug Picture
Figure Pyelonephritis Drug Industry Chain Diagram
Figure Global Pyelonephritis Drug Sales Revenue 2015-2018E, in USD Million
Figure Global Pyelonephritis Drug Sales Volume 2015-2018E, in Volume
Figure Global Pyelonephritis Drug Market Status by Type 2015-2018E, in Volume
Figure North America Pyelonephritis Drug Market Size and Growth 2015-2018E, in USD Million
Figure North America Pyelonephritis Drug Market Size and Growth 2015-2018E, in Volume
Figure Europe Pyelonephritis Drug Market Size and Growth 2015-2018E, in USD Million
Figure Europe Pyelonephritis Drug Market Size and Growth 2015-2018E, in Volume
Figure Asia-Pacific Pyelonephritis Drug Market Size and Growth 2015-2018E, in USD Million
Figure Asia-Pacific Pyelonephritis Drug Market Size and Growth 2015-2018E, in Volume
Figure South America Pyelonephritis Drug Market Size and Growth 2015-2018E, in USD Million
Figure South America Pyelonephritis Drug Market Size and Growth 2015-2018E, in Volume
Figure Middle East Pyelonephritis Drug Market Size and Growth 2015-2018E, in USD Million
Figure Middle East Pyelonephritis Drug Market Size and Growth 2015-2018E, in Volume
Figure Africa Pyelonephritis Drug Market Size and Growth 2015-2018E, in USD Million
Figure Africa Pyelonephritis Drug Market Size and Growth 2015-2018E, in Volume
Figure Global Pyelonephritis Drug Sales Revenue Forecast 2019F-2025F, in USD Million
Figure Global Pyelonephritis Drug Sales Volume Forecast 2019F-2025F, in Volume
Figure Global Pyelonephritis Drug Sales Price Forecast 2019F-2025F
Figure Global Pyelonephritis Drug Gross Margin Forecast 2019F-2025F
Figure Global Pyelonephritis Drug Sales Revenue by Company in 2018, in USD Million
Figure Global Pyelonephritis Drug Price by Company in 2018
Figure Global Pyelonephritis Drug Gross Margin by Company in 2018


More Publications